Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Uncovering Electron-Transfer Mechanisms of Sulfur Anion Photosensitizers with Intramolecular Charge Transfer.

Journal of the American Chemical Society·2026

Same author

Tailored Biomaterials Induce Tertiary Lymphoid Structures for Boosting Cancer Immunotherapy.

ACS nano·2026

Same author

Quaternary Carbons from Amines and Acids.

Journal of the American Chemical Society·2026

Same author

FSTL3-Driven Cuproptosis Resistance and EPCs Promote OSCC Metastasis.

Journal of dental research·2026

Same author

Alternating Current-Promoted Copper Catalysis for the Construction of Alkynyl Thioethers.

The Journal of organic chemistry·2026

Same author

Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player.

Oncogene·2026

Search research articles

Related Experiment Video

Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Tumor-Targeted Catalytic Immunotherapy.

En-Li Yang¹, Wu-Yin Wang¹, Ying-Qi Liu¹

¹The State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430079, China.

Advanced Materials (Deerfield Beach, Fla.)

|December 16, 2024

Summary

This summary is machine-generated.

Advanced catalytic materials can improve cancer immunotherapy by targeting the tumor microenvironment (TME). This review explores tumor-targeted catalytic materials and their mechanisms for enhanced cancer treatment efficacy.

Keywords:

cancer immunotherapy catalytic material targeted therapy tumor microenvironment

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Experiment Videos

Last Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Area of Science:

Biomedical Engineering
Materials Science
Oncology

Background:

Cancer immunotherapy shows promise but suffers from low response rates.
The immunosuppressive tumor microenvironment (TME) limits treatment efficacy.
Targeted catalytic materials offer a strategy to modulate the TME and enhance immunotherapy.

Purpose of the Study:

To provide a comprehensive overview of tumor-targeted catalytic materials for enhanced cancer immunotherapy.
To systematically review advancements, mechanisms, and targeting strategies.
To discuss challenges and future clinical translation.

Main Methods:

Literature review of recent advancements in tumor-targeted catalytic materials.
Analysis of catalytic reactions, material construction, and targeting mechanisms.
Examination of various tumor-specific targeting strategies.

Main Results:

Catalytic materials can precisely modulate the immunosuppressive TME via biochemical reactions.
Key targeting mechanisms include passive, bioactive, stimuli-responsive, and biomimetic approaches.
Multiple tumor-specific targeting strategies are identified, including TME-responsive methods.

Conclusions:

Tumor-targeted catalytic materials are crucial for improving catalytic immunotherapy efficacy.
Understanding targeting mechanisms is essential for optimal therapeutic outcomes.
Addressing challenges in clinical translation is key for next-generation cancer therapies.